Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pacs Group Inc. (PACS:NYSE), powered by AI.
Pacs Group Inc. is currently trading at $35.89. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Pacs Group Inc. on Alpha Lenz.
Pacs Group Inc.'s P/E ratio is 29.3.
“Pacs Group Inc. trades at a P/E of 29.3 (premium valuation) with strong ROE of 23.1%. 3Y revenue CAGR of 29.7% highlights clear growth momentum.”
Ask for details →Pacs Group Inc. focuses on providing integrated packaging solutions to various industries worldwide. As a company in the manufacturing sector, it specializes in producing innovative and sustainable packaging materials designed to enhance the efficiency and aesthetic appeal of consumer goods. Its product offerings cater to a diverse array of industries, including food and beverage, personal care, pharmaceuticals, and industrial goods. Pacs Group Inc. utilizes cutting-edge technology and environmentally friendly materials to address growing consumer demand for sustainable packaging. The company's dedication to research and development is evident in its continuous efforts to introduce packaging solutions that reduce environmental impact while maintaining product integrity. By fostering collaborations with leading manufacturers and retailers, Pacs Group Inc. plays a vital role in the global supply chain, ensuring that products are delivered safely and attractively to end consumers. Operating in the competitive landscape of the packaging industry, Pacs Group Inc. positions itself as a key player committed to innovation and sustainability.
“Pacs Group Inc. trades at a P/E of 29.3 (premium valuation) with strong ROE of 23.1%. 3Y revenue CAGR of 29.7% highlights clear growth momentum.”
Ask for details →Pacs Group Inc. (ticker: PACS) is a company listed on NYSE in the Healthcare sector (Medical Care Facilities). It has approximately 32,433 employees. Market cap is $5.6B.
The current price is $35.89 with a P/E ratio of 29.26x and P/B of 5.92x.
ROE is 23.13% and operating margin is 5.85%. Annual revenue is $5.3B.